/Investor DB

Kaiser Permanente Ventures — 2020 Investments

4 investments dated 2020 · listed companies and verified rows first · show all

BioAge Labsbioagelabs.comin𝕏NASDAQ: BIOADec 2020

BIOAGE develops therapies targeting the molecular pathways that drive aging to increase healthspan and address age-related chronic diseases.

BiotechHealthtechLongevityRichmond, US

Kristen Fortney, PhD(Co-Founder, CEO)Eric Morgen, MD(Co-Founder, COO)Kristen Fortney(Founder)inEric Morgen(Founder)inDov Goldstein(Executive Officer)in

BoardPatrick Enright(Director)in

Co-investorsAndreessen HorowitzElad GilFelicis VenturesGreen Sands EquityIA Seed VenturesLongitude Capital+19 more

OSSO VRossovr.comin𝕏Jul 2020

Osso develops virtual reality training scenarios for nurses, nurse leaders and healthcare system administrators, offering self-guided learning, skill assessment, and collaborative training on one platform.

Digital HealthEdTechHealthtechMillbrae, US

Justin Barad(Founder)inHeather Gervais(CEO)inHarvard-trained pediatric(Founder)Matt Newport(Founder)

Board seatAmy Belt Raimundo· per SEC Form D

Co-investorsInformed Ventures Advisors, LlcOak HC/FTPresence CapitalScrum VenturesSignalFireAnorak Ventures+1 more

Ordrordr.netin𝕏Series B · Mar 2020 · $34M

Ordr provides a device intelligence and network security platform that identifies and protects connected assets across cloud, on-premises, and SaaS environments.

Cloud ComputingCybersecurityEnterprise SoftwareIoT

Pandian Gnanaprakasam(Founder)Sheausong Yang(Founder)

Co-investorsBattery VenturesTen ElevenUnusual VenturesWing

Sleepiosleepio.cominJun 2020 · $39M

App to improve mental health and insomnia

Co-investorsGilde HealthcareIndex VenturesOctopus VenturesSamsung Next

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.